Items where authors include "Tong, A."

Article

Goodyear, C.S., Patel, A., Barnes, E. et al. (118 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Goodyear, C.S., Patel, A., Barnes, E. et al. (119 more authors) (2024) Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial. The Lancet Rheumatology, 6 (6). e339-e351. ISSN 2665-9913

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine. ISSN 1078-8956

Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29 (7). pp. 1760-1774. ISSN 1078-8956

Cho, Y., Tong, A., Craig, J.C. et al. (28 more authors) (2021) Establishing a core outcome set for autosomal dominant polycystic kidney disease : report of the Standardized Outcomes in Nephrology–Polycystic Kidney Disease (SONG-PKD) consensus workshop. American Journal of Kidney Diseases, 77 (2). pp. 255-263. ISSN 0272-6386

Logeman, C., Cho, Y., Sautenet, B. et al. (27 more authors) (2020) ‘A sword of Damocles’ : patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study. BMJ Open, 10 (10). e038005.

Cho, Y., Rangan, G., Logeman, C. et al. (25 more authors) (2020) Core outcome domains for trials in autosomal dominant polycystic kidney disease: An international Delphi survey. American Journal of Kidney Diseases, 76 (3). pp. 361-373. ISSN 0272-6386

Sautenet, B., Cho, Y., Gutman, T. et al. (15 more authors) (2020) Range and variability of outcomes reported in randomized trials conducted in patients with polycystic kidney disease: A systematic review. American Journal of Kidney Diseases, 76 (2). pp. 213-223. ISSN 0272-6386

Cho, Y., Sautenet, B., Gutman, T. orcid.org/0000-0002-6341-8725 et al. (26 more authors) (2019) Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study. Nephrology, 24 (12). pp. 1214-1224. ISSN 1320-5358

Tong, A., Manns, B., Wang, A.Y.M. et al. (202 more authors) (2018) Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney International, 94 (6). pp. 1053-1068. ISSN 0085-2538

Cho, Y. orcid.org/0000-0002-3502-9837, Sautenet, B., Rangan, G. et al. (21 more authors) (2017) Standardised outcomes in nephrology-polycystic kidney disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease. Trials, 18. 560. ISSN 1745-6215

Book Section

Booth, A. orcid.org/0000-0003-4808-3880, Hannes, K., Harden, A. et al. (3 more authors) (2014) COREQ (Consolidated Criteria for Reporting Qualitative Studies). In: Moher, D., Altman, D.G., Schulz, K.F., Simera, I. and Wager, E., (eds.) Guidelines for Reporting Health Research: A User's Manual. Wiley , pp. 214-226. ISBN 9780470670446